NCT06390423

Brief Summary

In the critically ill population, fluid administration in an unstable patient is perhaps the most common intervention that is performed. Uncorrected hypovolemia with inappropriate vasopressors lead to organ hypoperfusion where as overzealous fluid administration especially in ARDS (Adult respiratory distress syndrome) can increase mortality. It has been estimated that only 50% of hemodynamically unstable critically ill patients are volume responsive, hence dynamic assessment of preload responsiveness has been proposed to better identify those individuals who would benefit from fluid bolus.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
64

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2023

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

April 25, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 30, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

August 22, 2024

Status Verified

August 1, 2024

Enrollment Period

1.9 years

First QC Date

April 25, 2024

Last Update Submit

August 20, 2024

Conditions

Keywords

Pre-load responsivenessPassive leg raiseMini-fluid challenge

Outcome Measures

Primary Outcomes (1)

  • Vasopressor dose in Nor-epinephrine equivalents (NE) measured as mcg/kg/min

    We shall assess the need for vasopressor dose e.g nor-epinephrine dose. If the dose remains constant after fluid bolus until 3 hours, we shall consider them fluid resposive. If the dose requirement goes up despite fluid bolus, we shall label them fluid un-responsive

    3 hours after the initial passive leg raise

Study Arms (2)

Fluid responder

Stability of vasopressor dose with maximum of 500 cc of crystalloids

Diagnostic Test: Passive leg raise, SVI via bioreactance, Echo based VTI

Fluid non responder

Escalating dose of vasopressors despite 1 L of crystalloid fluid challenge

Interventions

No interventions other than fluid challenge

Fluid responder

Eligibility Criteria

Age30 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Screening criteria: 1. New onset of hypotension: MAP \< 65 mm HG for \> 5 min 2. Escalation in Nor-epinephrine needs\> 0.03 ug/kg/min 3. High MAP goal Low Urine output \< 0.5ml/kg/hr for \> 2 hours Elevated Lactate \> 4 moles/L Decreased Lactate clearance (\< 40%) 4. Bedside Echo Inc. VTI No obvious Hypovolemia No Low EF or No Pericardial effusion

You may qualify if:

  • Age between 30 - 90 years
  • Diagnosis of Vasodilatory Shock with no other obvious cause of hypotension
  • Diagnosis of ARDS with PF ratio \< 150 , PEEP \> 8
  • Patients who are under paralysis or deeply sedated, on a mechanical ventilator

You may not qualify if:

  • Patients with arrhythmias including atrial fibrillation
  • Patients with chest tube, intra-abdominal hypertension or with its risk factors
  • Patients with structural heart disease including pulmonary hypertension (RVSP \> 45) and heart failure
  • Patients on extracorporeal support such as ECMO, CRRT or MCS.
  • Patients with COPD with a premorbid FEV1 \< 1.5 L
  • Severe atherosclerotic vascular disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St Cloud Hospital

Saint Cloud, Minnesota, 56303, United States

RECRUITING

Related Publications (2)

  • Monnet X, Teboul JL. Passive leg raising: five rules, not a drop of fluid! Crit Care. 2015 Jan 14;19(1):18. doi: 10.1186/s13054-014-0708-5. No abstract available.

    PMID: 25658678BACKGROUND
  • Monnet X, Bataille A, Magalhaes E, Barrois J, Le Corre M, Gosset C, Guerin L, Richard C, Teboul JL. End-tidal carbon dioxide is better than arterial pressure for predicting volume responsiveness by the passive leg raising test. Intensive Care Med. 2013 Jan;39(1):93-100. doi: 10.1007/s00134-012-2693-y. Epub 2012 Sep 19.

    PMID: 22990869BACKGROUND

Study Officials

  • Ramakanth Pata, MD FCCP

    Centracare health System

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 25, 2024

First Posted

April 30, 2024

Study Start

July 1, 2023

Primary Completion

June 1, 2025

Study Completion

June 1, 2025

Last Updated

August 22, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations